News

Latest News

  • March 21, 2024

    Aptitude's Metrix® platform is highlighted in Nature.

    Read More

  • January 3, 2024

    Aptitude partners with Sekisui Diagnostics to expand distribution of Metrix® COVID-19 test.

    Read More

  • October 1, 2023

    Aptitude launches sale of Metrix® COVID-19 test on Amazon.com.

  • September 1, 2023

    Aptitude launches ecommerce site for sale of Metrix® COVID-19 test.

  • July 24, 2023

    Aptitude partners with Bill & Melinda Gates Foundation (BMGF) to accelerate the commercialization of the Metrix® Multiplex STI panel for Point-of-Care and Over-the-Counter use. This product will transform access to critical diagnostic information in the domestic market and in Low and Middle Income Countries.

    Read More

  • April 20, 2023

    Aptitude Receives up to $54 Million Partnership with BARDA to Develop Diagnostics for Point-of-Care and At-Home Use.

    Read More

  • October 18, 2022

    Aptitude received FDA Emergency Use Authorization for the Metrix® COVID-19 Test, the world's first saliva/swab based molecular test for at-home and over-the-counter use without physician supervision.

    Read More

  • August 3, 2022

    Aptitude submitted request to the FDA for Emergency Use Authorization seeking first saliva/swab based molecular over-the-counter COVID-19 test.

  • January 27, 2021

    Aptitude has received multi-million dollar funding to develop its next-generation molecular diagnostics platform through regulatory approval.

  • December 21, 2020

    Aptitude received California Clinical Laboratory Improvement Amendments (CLIA) license for high-complexity molecular testing.

  • July 10, 2020

    Aptitude was admitted into the prestigious NIH RADx program to develop COVID-19 tests that are easier to use, easier to access, and more accurate.

Latest Events and Attendances

  • January 2024

    Aptitude will attend JP Morgan Healthcare Conference, San Francisco, CA.

  • November 2023

    Aptitude will present at the Research and Innovation Translation Partnerships in Point-of-Care Technologies Conference and Technology (POCTRN) Showcase, Bethesda, MD.

  • October 2023

    Aptitude will give an invited presentation at Gates Grand Challenges 2023,  Dakar Senegal.

  • October 2023

    Aptitude will attend HLTH 2023 in Las Vegas, NV.

  • September 2023

    Aptitude will give an invited presentation at the ACME POCT Oliver Brand Memorial Lecture, Emory University.

  • August 2023

    Aptitude will attend the annual Military Health System Research Symposium (MHSRS) in Kissimmee, FL.

  • July 2023

    Aptitude will attend the AACC Annual Scientific Meeting & Clinical Lab Expo in Anaheim, CA.
    Visit us at booth #1468.

  • March 2023

    Aptitude will attend the HIDA Executive Conference in Bonita Springs, FL.

  • March 2023

    Aptitude will attend the LSI Emerging Medtech Summit in Dana Point, CA.

  • February 2023

    Aptitude will attend the 7th SABPA Annual Frontiers in Therapeutics and Diagnostics Forum in Del Mar, CA.

  • January 2023

    Aptitude will attend the J.P. Morgan Healthcare Conference in San Francisco, CA.

  • September 2022

    Aptitude will attend the HIDA Streamlining Healthcare Expo & Business Exchange in Chicago, IL.

  • August 2022

    Aptitude will attend the annual Military Health System Research Symposium (MHSRS) in Kissimmee, FL.

  • July 2022

    Aptitude will attend the AACC Annual Scientific Meeting & Clinical Lab Expo in Chicago, IL.